Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma

Overview of attention for article published in Frontiers in oncology, February 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 13,545 followers.

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma #FrontOncol #MassSpec https://t.co/1dMHrf7S0h

18 Mar 2022

Reply Repost Favourite

New article: Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma https://t.co/FqfQuJhVG5 #MMSM #MultipleMyeloma #hematology https://t.co/EwWZSRBVjV

18 Mar 2022

Reply Repost Favourite

New research: Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma: Aims To evaluate abnormal metabolites related to treatment response and prognosis of multiple myeloma (MM) patients… https://t.co

28 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.